OBJECTIVE: To determine whether a population of pregnant women with group B streptococcal (GBS) vaginal colonization had an increased risk of specific epidemiological and intrapartum risk factors for early onset GBS disease. SETTING: Tertiary university centre in Ottawa, Ontario. DESIGN: Hospital-based retrospective cohort study. METHODS: Pregnant women who gave birth during a four-month period in 1994 were included in the study. Potential GBS risk factors were obtained from a review of medical records. The prevalence of each risk factor in colonized and noncolonized women was examined using chi(2) or Fisher's exact test. Multiple logistic regression was performed. RESULTS: A total of 986 women, including 94 (9.5%) women colonized with GBS, were studied. The proportion of women younger than 20 years of age in the colonized group was 2.1% (two of 94) versus 4.6% (41 of 891) in the noncolonized group (P=0.28). Similar rates of multiple births were observed among the colonized and noncolonized groups (2.1% [two of 94] versus 2.5% [22 of 891], respectively) (P=0.94). Likewise, there were no significant differences in either group in the prevalence of a previous pregnancy affected by GBS or diabetes mellitus (P=0.82 and P=0.79, respectively). Multivariable analyses indicated that women who were colonized with GBS were more than twice as likely to deliver prematurely (below 37 weeks' gestational age) (odds ratio [OR] 2.43, 95% CI 1.39 to 4.23). Similarly, colonized women were more likely to be febrile during labour (at least 38 degrees C) (OR 5.05, 95% CI 1.70 to 15.02). CONCLUSION: GBS vaginal colonization was associated with premature labour and intrapartum pyrexia in the population studied. According to Canadian and American guidelines, women with GBS vaginal colonization qualify for intrapartum chemoprophylaxis. The study results suggest that the identification of women at risk of premature labour may be one advantage of early prenatal screening for GBS.
OBJECTIVE: To determine whether a population of pregnant women with group B streptococcal (GBS) vaginal colonization had an increased risk of specific epidemiological and intrapartum risk factors for early onset GBS disease. SETTING: Tertiary university centre in Ottawa, Ontario. DESIGN: Hospital-based retrospective cohort study. METHODS: Pregnant women who gave birth during a four-month period in 1994 were included in the study. Potential GBS risk factors were obtained from a review of medical records. The prevalence of each risk factor in colonized and noncolonized women was examined using chi(2) or Fisher's exact test. Multiple logistic regression was performed. RESULTS: A total of 986 women, including 94 (9.5%) women colonized with GBS, were studied. The proportion of women younger than 20 years of age in the colonized group was 2.1% (two of 94) versus 4.6% (41 of 891) in the noncolonized group (P=0.28). Similar rates of multiple births were observed among the colonized and noncolonized groups (2.1% [two of 94] versus 2.5% [22 of 891], respectively) (P=0.94). Likewise, there were no significant differences in either group in the prevalence of a previous pregnancy affected by GBS or diabetes mellitus (P=0.82 and P=0.79, respectively). Multivariable analyses indicated that women who were colonized with GBS were more than twice as likely to deliver prematurely (below 37 weeks' gestational age) (odds ratio [OR] 2.43, 95% CI 1.39 to 4.23). Similarly, colonized women were more likely to be febrile during labour (at least 38 degrees C) (OR 5.05, 95% CI 1.70 to 15.02). CONCLUSION:GBS vaginal colonization was associated with premature labour and intrapartum pyrexia in the population studied. According to Canadian and American guidelines, women with GBS vaginal colonization qualify for intrapartum chemoprophylaxis. The study results suggest that the identification of women at risk of premature labour may be one advantage of early prenatal screening for GBS.
Authors: Jay Vornhagen; Blair Armistead; Verónica Santana-Ufret; Claire Gendrin; Sean Merillat; Michelle Coleman; Phoenicia Quach; Erica Boldenow; Varchita Alishetti; Christina Leonhard-Melief; Lisa Y Ngo; Christopher Whidbey; Kelly S Doran; Chad Curtis; Kristina M Adams Waldorf; Elizabeth Nance; Lakshmi Rajagopal Journal: J Clin Invest Date: 2018-04-09 Impact factor: 14.808
Authors: Lindsey R Burcham; Madeline S Akbari; Norhan Alhajjar; Rebecca A Keogh; Jana N Radin; Thomas E Kehl-Fie; Ashton T Belew; Najib M El-Sayed; Kevin S McIver; Kelly S Doran Journal: mBio Date: 2022-06-06 Impact factor: 7.786
Authors: Hae-Ryung Park; Sean M Harris; Erica Boldenow; Richard C McEachin; Maureen Sartor; Mark Chames; Rita Loch-Caruso Journal: Biol Reprod Date: 2018-03-01 Impact factor: 4.285
Authors: Jay Vornhagen; Phoenicia Quach; Erica Boldenow; Sean Merillat; Christopher Whidbey; Lisa Y Ngo; K M Adams Waldorf; Lakshmi Rajagopal Journal: mBio Date: 2016-06-28 Impact factor: 7.867
Authors: Nicole M Gilbert; Lynne R Foster; Bin Cao; Yin Yin; Indira U Mysorekar; Amanda L Lewis Journal: Am J Obstet Gynecol Date: 2020-11-26 Impact factor: 8.661